| DAPY |
diarylpyrimidine |
| NNRTI |
nonnucleoside reverse transcriptase inhibitor |
| AIDS |
acquired immunodeficiency syndrome |
| 3D-QSAR |
three-dimensional quantitative structure-activity relationship |
| CoMFA |
comparative molecular field analysis |
| CoMSIA |
comparative molecular similarity indices analysis |
| HIV |
human immunodeficiency virus |
| HAART |
highly active antiretroviral therapy |
| RT |
reverse transcriptase |
| HIV-1 |
HIV type 1 |
| WT |
wild-type |
| CAPY |
cycloalkyl arylpyrimidine |
|
|
cross-validated correlation coefficient |
| ONC |
optimal number of components |
|
|
non-cross-validated correlation coefficient |
|
|
predictive correlation coefficient |
| SEE |
standard error of estimate |
| F |
F-statistic values |
| RMSE |
root mean square error |
| MAE |
mean absolute error |
| GALAHAD |
Genetic Algorithm with Linear Assignment of Hypermolecular Alignment of Datasets |
| SE |
strain energy |
| SO |
steric overlap |
| PhS |
pharmacophoric similarity |
| DA |
hydrogen-bond donor atom |
| AA |
hydrogen-bond acceptor atom |
| HY |
hydrophobe |
| RMSD |
root-mean-square deviation |
| LOO |
leave one out |
| SDEP |
standard deviation error of predictions |
| PRESS |
predicted residuals sum of squares |